We'll pursue vertically integrated business models in tightly-regulated markets.
We’ll leverage our holdings to build enduring brands and intellectual property and expand distribution.
We’ve emerged as one of the world’s fastest-growing, premium plant driven-lifestyle company by effectively deploying capital to build a diversified portfolio of successful cannabis brands.
We deeply believe in the transformational power that cannabis has to heal and change the world.
We have the most diverse holdings of any company in the cannabis industry, with operations that include a mix of cultivation and production facilities, dispensaries, and vertically integrated cannabis companies across the country.
We’ll use our institutional operational knowledge to drive efficiencies and create differentiated brands for national and international expansion.
Research has shown that cannabis or cannabinoids are effective for treatment of various medical conditions, including chronic pain. As a result, cannabis was legalized for medical use in Canada in 2001.
The number of medical marijuana patients in Canada is growing at a compound monthly rate of over 9% per month. This is notwithstanding that many medical doctors are more likely to prescribe highly addictive opioids (morphine, fentanyl, oxycontin) rather than marijuana. Using US data as a proxy, it is estimated that the Canadian medical marijuana market could be worth over $3 billion.
Canaccord Genuity has estimated that there are 3.8M potential recreational marijuana users in Canada. Extrapolating US consumer usage shows the Canadian recreational market could be worth $5B - $8B per year, which approximates the size of the spirits market ($5B) and wine market ($7B) in Canada.